Cluster analysis in patients with GOLD 1 chronic obstructive pulmonary disease

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Gagnon, Philippe ^a   Casaburi, Richard ^b   Saey, Didier ^a   Porszasz, Janos ^b   Provencher, Steeve ^a   Milot, Julie ^a   Bourbeau, Jean ^c   O'Donnell, Denis E ^d   Maltais, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL RESIDUAL CAPACITY; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GRADE 1; HUMAN; INSPIRATORY CAPACITY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYSICAL ACTIVITY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RESIDUAL VOLUME; SMOKING; TOTAL LUNG CAPACITY; CASE CONTROL STUDY; CLINICAL TRIAL; CLUSTER ANALYSIS; EXERCISE; PATHOPHYSIOLOGY;

CASE-CONTROL STUDIES; CLUSTER ANALYSIS; EXERCISE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 84929327616     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123626     Document Type: Article

References (40)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. January 2014. Available: http://www.goldcopd.org/uploads/users/files/GOLD-Report-2014-Jan23.pdf. Accessed 29 April 2014.
2. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187: 347-365. doi: 10.1164/rccm.201204-0596PP PMID: 22878278
3. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J. 2010; 36: 531-539. doi: 10.1183/09031936.00175109 PMID: 20075045
4. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370: 741-750. PMID: 17765523
5. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. November 2006. Available: http://www.goldcopd.org/uploads/users/files/GOLDReport2006-0122.pdf. Accessed 29 April 2014.
6. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010; 182: 598-604. doi: 10.1164/rccm.200912-1843CC PMID: 20522794
7. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax. 2007; 62: 237-241. PMID: 17090573
8. Kerstjens HA. The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med. 2004; 170: 212-213. PMID: 15280172
9. Petsonk EL, Hnizdo E, Attfield M. Definition of COPD GOLD stage I. Thorax. 2007; 62: 1107-1108. PMID: 18025146
10. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010; 11: 122. doi: 10.1186/1465-9921-11-122 PMID: 20831787
11. O'Donnell DE, Maltais F, Porszasz J, Webb KA, Albers FC, Deng Q, et al. The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial. PLoS ONE. 2014; 9: e96574. doi: 10.1371/journal.pone.0096574 PMID: 24788342
12. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984; 85: 751-758. PMID: 6723384
13. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26: 948-968. PMID: 16264058
14. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16: 5-40. PMID: 8499054
15. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999; 159: 179-187. PMID: 9872837
16. Gandevia B, Hugh-Jones P. Terminology for measurements of ventilatory capacity; a report to the thoracic society. Thorax. 1957; 12: 290-293. PMID: 13496030
17. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992; 47: 1019-1024. PMID: 1494764
18. Gagnon P, Saey D, Provencher S, Milot J, Bourbeau J, Tan WC, et al. Walking exercise response to bronchodilation in mild COPD: a randomized trial. Respir Med. 2012; 106: 1695-1705. doi: 10.1016/j.rmed.2012.08.021 PMID: 22999808
19. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14: 377-381. PMID: 7154893
20. Porszasz J, Casaburi R, Somfay A, Woodhouse LJ, Whipp BJ. A treadmill ramp protocol using simultaneous changes in speed and grade. Med Sci Sports Exerc. 2003; 35: 1596-1603. PMID: 12972882
21. McLachlan GJ. Cluster analysis and related techniques in medical research. Stat Methods Med Res. 1992; 1: 27-48. PMID: 1341650
22. Art D, Gnanadesikan R, Kettenring R (1982) Data-based metrics for cluster analysis. Utilitas Mathematica. pp. 75-99.
23. Weatherall M, Shirtcliffe P, Travers J, Beasley R. Use of cluster analysis to define COPD phenotypes. Eur Respir J. 2010; 36: 472-474. doi: 10.1183/09031936.00035210 PMID: 20930198
24. Milligan GW, Cooper MC. An examination of pocedures for determining the number of clusters in a data set. Psychometrika. 1985; 50: 159-179.
25. Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 1963; 58: 236-244.
26. 1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63: 1046-1051. doi: 10.1136/thx.2008.098483 PMID: 18786983
27. Deesomchok A, Webb KA, Forkert L, Lam YM, Ofir D, Jensen D, et al. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. COPD. 2010; 7: 428-437. doi: 10.3109/15412555.2010.528087 PMID: 21166631
28. Guenette JA, Jensen D, Webb KA, Ofir D, Raghavan N, O'Donnell DE. Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms. Respiratory physiology & neurobiology. 2011; 177: 218-227.
29. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J. 2010; 35: 676-680. doi: 10.1183/09031936.00120609 PMID: 20190332
30. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 177: 622-629. PMID: 18006885
31. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010; 104: 1005-1011. doi: 10.1016/j.rmed.2010.01.012 PMID: 20167463
32. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009; 33: 262-272. doi: 10.1183/09031936.00024608 PMID: 19010994
33. Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, et al. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012; 142: 338-346. PMID: 22281798
34. Waschki B, Kirsten A, Holz O, Müller KC, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011; 140: 331-342. doi: 10.1378/chest.10-2521 PMID: 21273294
35. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An Official American Thoracic Society/European Respiratory Society Statement: Key concepts and advances in pulmonary rehabilitation - An Executive Summary. Am J Respir Crit Care Med. 2013; 188: e13-e64. doi: 10.1164/rccm.201309-1634ST PMID: 24127811
36. Van Remoortel H, Hornikx M, Demeyer H, Langer D, Burtin C, Decramer M, et al. Daily physical activity in subjects with newly diagnosed COPD. Thorax. 2013; 68: 962-963. doi: 10.1136/thoraxjnl-2013-203534 PMID: 23604460
37. Sue DY, Hansen JE. Normal values in adults during exercise testing. Clin Chest Med. 1984; 5: 89-98. PMID: 6723246
38. Coronell C, Orozco-Levi M, Méndez R, Ramírez-Sarmiento A, Gáldiz JB, Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J. 2004; 24: 129-136. PMID: 15293615
39. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010; 36: 81-88. doi: 10.1183/09031936.00104909 PMID: 19897554
40. Eagan TM, Gulsvik A, Eide GE, Bakke PS. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. Eur Respir J. 2004; 23: 589-594. PMID: 15083759